on Quantum Biopharma Ltd.
Quantum BioPharma to Present at Global Growth and Investment Conference
Quantum BioPharma Ltd. (NASDAQ:QNTM), a biopharmaceutical company, announced that Jason Sawyer, Head of Finance and Mergers and Acquisitions, will present at the ArcStone-Kingswood Growth Summit. The event takes place on September 26, 2024, in Toronto, ON, featuring over 30 companies and 47 sponsors globally.
Mr. Sawyer will discuss the company's growth potential and engage with key investors. The summit aims to foster valuable public companies that benefit both management and investors. The event will be held at the Sheraton Hotel in downtown Toronto.
Quantum BioPharma focuses on innovative biotech solutions for neurodegenerative and metabolic disorders. The company retains strategic investments through its subsidiary, FSD Strategic Investments Inc.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Quantum Biopharma Ltd. news